Executive pay changes and 2026 incentive plan approval at Integer (NYSE: ITGR)
Integer Holdings Corporation announced significant compensation and governance updates, including amended employment terms for CEO Payman Khales and other executives to protect performance-based equity upon a change in control. The company also approved cash retention bonuses for key executives, totaling $1,750,000 for Mr. Khales. Stockholders further approved the 2026 Omnibus Incentive Plan, replacing the prior plan and reserving shares for future awards, alongside electing directors and ratifying auditors at the annual meeting.
Integer Holdings (ITGR) exec exercises 1,963 RSUs and withholds 479 shares for taxes
Integer Holdings Corp's President, CRM & Neuro, Jim Stephens, exercised 1,963 restricted stock units (RSUs) on May 15, 2026. To cover tax obligations, 479 of these common shares were disposed of in a tax-withholding transaction, not an open-market sale. This activity is considered a routine equity compensation event, reflecting the vesting of previously granted RSUs.
Integer Holdings Corporation (ITGR) Stock Analysis: Healthcare Innovator with 10% Upside Potential
Integer Holdings Corporation (ITGR), a medical device manufacturer with a market cap of $2.99 billion, presents an intriguing investment opportunity due to its robust market presence and a potential upside of 10.28% based on analyst projections. Despite a modest revenue growth of 0.50%, the company demonstrates solid financial performance with an EPS of 4.03 and ROE of 8.59%, backed by $98.1 million in free cash flow. Analysts have a favorable outlook, with six buy ratings and four hold ratings, indicating confidence in ITGR's strategic direction and market opportunities in the healthcare sector.
Charles Schwab Investment Management Inc. Grows Stock Position in Integer Holdings Corporation $ITGR
Charles Schwab Investment Management Inc. increased its stake in Integer Holdings Corporation (NYSE:ITGR) by 7.3% in the fourth quarter, bringing its total to 437,964 shares valued at $34.35 million. Other institutional investors also adjusted their positions, with hedge funds and institutions now owning 99.29% of the stock. Integer recently reported quarterly earnings, missing EPS estimates slightly but exceeding revenue expectations, and current analyst ratings average a "Hold" with a target price of $98.29.
Sea Cliff Partners Management Increases Integer Holdings Position Ahead of Strategic Review - News and Statistics
Sea Cliff Partners Management increased its stake in Integer Holdings by 55,359 shares, a transaction valued at approximately $4.71 million, bringing their total position to $16.57 million. This strategic purchase occurred before Integer Holdings announced a strategic review, suggesting the fund views the company's recent struggles as an opportunity for value creation, potentially through a sale or merger. The medical device manufacturer has faced decelerating growth and product-related challenges, leading to a 25% share price decline over the past year.
Oppenheimer upgrades Integer Holding stock rating on strategic review
Oppenheimer has upgraded Integer Holding (NYSE:ITGR) to Outperform from Perform, setting a price target of $115.00, suggesting significant upside potential from its current trading price of $84.98. This upgrade follows Integer Holding's strategic review process and is supported by InvestingPro data indicating the stock is undervalued with a fair value of $103.57. Despite an uncertain macro environment and recent downward revision of full-year 2026 guidance, Oppenheimer sees a favorable risk-reward profile, noting the company is trading at a low P/E ratio relative to near-term earnings growth.
Oppenheimer Upgrades Integer Holdings to Outperform From Market Perform, Price Target Is $115
Oppenheimer has upgraded Integer Holdings (NYSE: ITGR) from Market Perform to Outperform, setting a price target of $115. This upgrade suggests a positive outlook for the company's stock performance.
[Form 4] Integer Holdings Corp Insider Trading Activity
Integer Holdings Corp's EVP and CFO, Diron Smith, reported equity compensation activity, exercising 2,063 restricted stock units (RSUs) into common shares on May 8, 2026. A total of 503 shares were withheld at $88.12 each to cover tax obligations. After these transactions, Smith directly holds approximately 12,918.83 shares of Integer Holdings common stock.
Integer Holdings Corporation (NYSE:ITGR) Given Consensus Rating of "Hold" by Analysts
Integer Holdings Corporation (NYSE:ITGR) has received a consensus "Hold" rating from analysts, with an average one-year price target of $98.29. The company reported mixed quarterly results, with adjusted EPS missing estimates but revenue exceeding expectations and increasing year-over-year. Shares last traded at $88.15, and institutional ownership remains high at 99.29%.
These analysts revise their forecasts on Integer Holdings after Q1 results
This article concerns Integer Holdings (ITGR) and how analysts have revised their forecasts following the company's first-quarter results. The revisions reflect new projections based on the latest financial performance data from Integer Holdings.
Integer Holdings Review Tests Shareholder Value As Profitability Improves
Integer Holdings (NYSE:ITGR) is undergoing a comprehensive review of its business and capital structure, exploring options like a sale or merger to maximize shareholder value. This review follows strong Q1 2026 results showing improved net income, despite softer sales guidance for the full year. The process, advised by Goldman Sachs and Davis Polk, introduces both potential for value creation and execution risks for investors.
Integer Holdings downgraded by Oppenheimer
Integer Holdings (ITGR) has been downgraded by Oppenheimer, according to an insight delivered by Quantisnow. Quantisnow is a real-time market data platform that aggregates various financial information for retail investors. The article also lists recent analyst ratings and SEC filings related to Integer Holdings.
Invesco Ltd. reports 1.97M ITGR shares (5.7%) — ITGR
Invesco Ltd. has filed a Schedule 13G, reporting beneficial ownership of 1,969,133 shares of Integer Holdings Corp (ITGR) common stock, which represents 5.7% of the class as of March 31, 2026. The filing indicates Invesco Ltd. has sole voting power over 1,959,066 shares and sole dispositive power over all 1,969,133 shares. This disclosure, signed by Robert R. Leveille, Global Head of Compliance, highlights the investment firm's significant passive stake in Integer Holdings Corp.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Integer Holdings Corporation (ITGR) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integer Holdings Corporation (NYSE:ITGR) who bought securities prior to July 25, 2024. The investigation aims to determine if Integer's officers and/or directors engaged in corporate wrongdoing. Investors are encouraged to contact the firm for further information at no cost.
Integer Holdings starts strategic review after Q1 beat; eyes sale or merger (update)
Integer Holdings announced it is undertaking a strategic review to explore a potential sale or merger, following a strong Q1 performance that beat analyst expectations. The company, a medical device outsource manufacturer, reported increased sales and adjusted earnings per share, and raised its full-year guidance. This review aims to maximize shareholder value amid ongoing industry consolidation and demand for innovative medical technologies.
Research Alert: CFRA Reiterates Hold Rating On Shares Of Integer Holdings Corporation
CFRA has reiterated its Hold rating on shares of Integer Holdings Corporation. This alert from CFRA informs investors of their continued neutral stance on the company's stock.
These Analysts Revise Their Forecasts On Integer Holdings After Q1 Results
Integer Holdings reported better-than-expected Q1 financial results, with earnings and sales surpassing analyst estimates. Despite this, the company cut its adjusted EPS and sales guidance for FY2026 due to anticipated headwinds and market dynamics. Following the announcement, Piper Sandler reiterated an Overweight rating and raised its price target, while Citigroup maintained a Neutral rating but lowered its price target.
Integer Holdings Corporation (NYSE:ITGR) Q1 2026 Earnings Call Transcript
Integer Holdings Corporation (NYSE: ITGR) reported its Q1 2026 earnings, missing EPS expectations by $0.01 with adjusted EPS of $1.20. The company updated its 2026 financial outlook, lowering sales expectations due to customer forecast adjustments and increasing risk adjustments, particularly impacting electrophysiology. Integer's board also announced the initiation of a strategic review to explore options for maximizing shareholder value, acknowledging heightened interest in the company.
Integer Holdings Earnings Call Flags Tough 2026
Integer Holdings reported mixed Q1 2026 results, with modest sales growth and benefits from share repurchases and lower interest costs. However, these positives were offset by pressure on margins, weaker cash flow, and a cut to its full-year 2026 guidance. The company's board has also initiated a strategic review to unlock shareholder value, positioning 2026 as a transitional year before projected growth reacceleration by 2027.
Integer Holdings Corporation Reports First Quarter 2026 Results
Integer Holdings Corporation (NYSE:ITGR) announced Q1 2026 results showing a 0.5% sales increase to $440 million, with organic growth of 1.3%. The company's financial performance was in line with expectations, despite headwinds from three new products, and they updated their 2026 outlook. Separately, Integer's Board of Directors initiated a strategic review to maximize stockholder value, considering options such as a sale or merger.
Earnings Call Summary | Integer Holdings(ITGR.US) Q1 2026 Earnings Conference
This is an earnings call summary for Integer Holdings (ITGR.US) Q1 2026 earnings conference. The specific details of the conference call are found in the cleaned content.
Strategic review at Integer (NYSE: ITGR) after mixed Q1 2026 earnings
Integer Holdings Corporation (NYSE: ITGR) reported mixed results for Q1 2026, with sales slightly up but adjusted earnings metrics declining, and announced a strategic review to maximize stockholder value. The review, supported by Goldman Sachs and Davis Polk, will explore various opportunities including a sale or merger, alongside the current standalone strategy. Despite near-term headwinds, Integer reaffirmed its 2026 sales and adjusted EPS guidance and expects to return to above-market organic sales growth in 2027.
Integer Holdings Q1 2026 slides: outlook cut on new product headwinds
Integer Holdings reported Q1 2026 earnings in line with expectations but revised its full-year guidance downwards due to new product headwinds and market dynamics in Electrophysiology. The company's stock fell 7.01% in pre-market trading despite beating analyst EPS estimates, as profitability declined and free cash flow weakened. A strategic review has been announced to maximize shareholder value, alongside a planned $50 million accelerated share repurchase program.
Earnings call transcript: Integer Holdings Q1 2026 beats forecasts, stock dips
Integer Holdings Corporation reported Q1 2026 earnings with EPS of $1.20 and revenue of $440 million, both surpassing analyst expectations. However, the stock dipped 7.01% pre-market due to a downward revision of full-year 2026 guidance and ongoing profitability and new product performance challenges. The company also announced that its board has initiated a strategic review to explore options for maximizing shareholder value due to heightened interest.
Integer Holdings Corporation 2026 Q1 - Results - Earnings Call Presentation (NYSE:ITGR) 2026-04-30
Integer Holdings Corporation (NYSE:ITGR) has released its Q1 2026 earnings call presentation. The company reported Q1 EPS of $1.20, beating estimates by $0.01, and revenue of $439.58 million, exceeding expectations by $13.58 million with a 0.50% year-over-year increase. This article provides access to the full slide deck presented during their earnings call.
Integer Holdings Corporation Reports First Quarter 2026 Results
Integer Holdings Corporation announced its Q1 2026 results, reporting sales of $440 million, a 0.5% increase, and a 1.3% organic growth. The company's financial performance was consistent with previous forecasts, despite headwinds from three new products, and they updated their 2026 outlook. Additionally, Integer's Board of Directors initiated a strategic review to explore options for maximizing stockholder value, which could include a sale or merger.
Integer Holdings starts strategic review after Q1 beat; eyes sale or merger (update) (ITGR:NYSE)
Integer Holdings (ITGR) has announced that its board of directors initiated a strategic review to explore various options, including a potential sale, merger, or business combination. This decision follows the company's strong first-quarter performance. The strategic review aims to unlock value for shareholders, while the company also continues its current standalone plan.
Integer: Q1 Earnings Snapshot
Integer Holdings Corp. (ITGR) reported first-quarter earnings of $16.5 million, or 48 cents per share, which adjusted to $1.20 per share. These adjusted earnings fell short of Wall Street's expectations of $1.21 per share. However, the medical device outsource manufacturer surpassed revenue forecasts, posting $439.6 million against an expected $426.6 million.
Vanguard (NASDAQ: ITGR) reports 6.03% stake in Integer Holdings
Vanguard Portfolio Management has reported a 6.03% passive stake in Integer Holdings (NASDAQ: ITGR), acquiring 2,076,935 shares of common stock as of March 31, 2026. This disclosure was made via a Schedule 13G SEC filing, indicating Vanguard holds sole dispositive power over all these shares and sole voting power for 29,969 shares. The filing highlights transparency in significant ownership stakes, showing no other entity holds more than 5% interest.
Integer Holdings earnings on deck as recovery from headwinds tested
Integer Holdings Corp (NYSE:ITGR) is preparing to release its first-quarter earnings, with analysts expecting a sequential decline in EPS and revenue due to previously flagged challenges in early 2026. The medical device manufacturer will be scrutinized for progress on its recovery plan, particularly regarding three underperforming new products, and for signs of health in its core business and product development pipeline. The report will test whether the company can navigate temporary headwinds and set the stage for promised growth acceleration later in the year.
Integer executives speak May 12 at Bank of America healthcare event
Integer Holdings Corporation (NYSE: ITGR), a medical device contract development and manufacturing organization, announced its participation in the 2026 Bank of America Healthcare Conference. Integer executives will hold a fireside chat on May 12, 2026, at 1:40 p.m. PT, with a live webcast and replay available on the company's investor relations website. This follows a trend of active investor outreach by Integer, with previous events often leading to modest stock price changes.
Integer Holdings Corporation (ITGR) Investigation: Bronstein, Gew
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing at Integer Holdings Corporation (NYSE: ITGR). The firm encourages investors who purchased Integer securities before July 25, 2024, and continue to hold them, to contact them for more information regarding the investigation. The firm operates on a contingency fee basis for these types of investor class actions.
Laurus Global Equity Management Inc. Lowers Position in Integer Holdings Corporation $ITGR
Laurus Global Equity Management Inc. significantly reduced its stake in Integer Holdings Corporation (ITGR) by 77.8% in Q4, selling 52,040 shares and retaining 14,860 shares valued at $1.165 million. Despite Integer beating Q4 earnings estimates with an EPS of $1.76 and revenue of $472.06 million, its stock traded down approximately 1.8%, and the company holds a consensus "Hold" rating with an average price target of $102. Insider selling by VP Tommy P. Thomas further occurred in March, reducing his position by 15.85%, while institutional investors maintain roughly 99.29% ownership.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integer Holdings Corporation (ITGR) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into Integer Holdings Corporation (ITGR) concerning potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging investors who purchased Integer securities before July 25, 2024, and still hold them, to come forward and assist with the investigation. The firm specializes in representing investors in securities fraud class actions on a contingency fee basis.
Integer (ITGR) to Release Earnings on Thursday
Integer (NYSE:ITGR) is scheduled to release its Q1 2026 earnings before market open on Thursday, April 30th. Analysts anticipate earnings of $1.19 per share and revenues of $426.48 million, with management providing a full-year 2026 EPS guidance of $6.29-$6.78. The medical equipment provider exceeded Q4 2025 estimates with $1.76 EPS and $472.06 million in revenue, demonstrating 5% year-over-year growth.
Integer Holdings (ITGR): Buy, Sell, or Hold Post Q4 Earnings?
This article analyzes Integer Holdings (ITGR) after its Q4 earnings, advising investors to avoid the stock despite a recent price drop. The author cites limited distribution channels due to small company size, projected revenue growth slowdown, and historically mediocre Return On Invested Capital (ROIC) as key reasons. While the valuation is reasonable, the underlying fundamentals present too much downside risk.
Integer Holdings Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics
Integer Holdings Corp., a small-cap company in the Pharmaceuticals & Biotechnology sector, has adjusted its stock valuation metrics to a P/E ratio of 28 and a price-to-book value of 1.66. The company has experienced varied stock performance, with a 15.01% year-to-date return but a 22.89% decline over the past year, underperforming the S&P 500. Its financial metrics also include an EV to EBIT of 18.70, EV to EBITDA of 11.69, ROCE of 7.45%, and ROE of 5.93%.
Investigation announced for LONG-TERM Investors in shares
An investigation has been launched on behalf of long-term investors in Integer Holdings Corporation (NYSE: ITGR) due to potential breaches of fiduciary duties by certain directors. This follows a lawsuit alleging securities law violations and concerns Integer's alleged overstatement of its competitive position and sustained deterioration in sales of its electrophysiology devices. Shareholders are encouraged to contact the Shareholders Foundation for options regarding the declining stock value.
Integer Holdings Corp stock (US45826J1051): Why Google Discover changes matter more now
Google's 2026 Discover Core Update, completed on February 27, 2026, is changing how investors receive news about Integer Holdings Corp (NYSE:ITGR) by delivering personalized insights directly to their Google app feed. This mobile-first shift provides faster access to critical developments like FDA approvals, clinical trial data, and M&A rumors, giving retail investors an advantage. By leveraging E-E-A-T principles, Discover prioritizes credible content from primary sources, making it easier for investors to track Integer's strategic moves, market dynamics, and financial performance without extensive searching.
Integer Holdings Corp stock (US45826J1051): Why Google Discover changes matter more now
Google's 2026 Discover Core Update is revolutionizing how investors access news on Integer Holdings Corp stock (NYSE:ITGR) by delivering personalized content directly to their mobile feeds. This shift allows for faster updates on critical developments like FDA approvals, clinical trial data, and M&A rumors, providing retail investors with a crucial edge in the fast-paced medical technology sector. The update prioritizes mobile-first, credible content that enhances real-time monitoring of Integer's strategic moves and market dynamics.
Integer Holdings Corp stock (US45826J1051): Why its medical device leadership matters more now for i
The article highlights Integer Holdings Corp's (US45826J1051) critical role as a supplier of specialized components for medical devices, particularly in cardiology and neuromodulation. It emphasizes the company's strong position due to increasing healthcare needs, an aging population, and the outsourcing trend in medtech. Investors are encouraged to consider Integer's consistent growth, strong financials, and exposure to high-growth medical fields as key drivers for long-term upside.
Integer Holdings Corp stock (US45826J1051): Why its medical device leadership matters more now for i
Integer Holdings Corp (ITGR) is a specialized medical device manufacturer focusing on high-margin areas like cardiac rhythm management and neuromodulation, benefiting from an aging population and increasing healthcare spending. The company's B2B model, long-term OEM contracts, and focus on outsourcing trends position it for steady demand. Integer's operational efficiency, solid balance sheet, and market leadership in custom manufacturing make it an attractive option for investors seeking defensive growth in the healthcare sector.
How Integer Holdings Corporation (ITGR) Affects Rotational Strategy Timing
This article from Stock Traders Daily analyzes Integer Holdings Corporation (ITGR) and its impact on rotational strategy timing. It highlights key findings like stable neutral readings in shorter horizons, potential easing of a long-term weak bias, and a significant risk-reward short setup. The analysis also provides AI-generated institutional trading strategies for different risk profiles and signals across various time horizons.
Medtech CDMO Integer discloses executive pay after new CEO steps in
Integer Holdings Corp., a medical device contract manufacturer, has disclosed the pay packages for its new CEO, Payman Khales, and other executives for 2025. Khales received $3.2 million in total compensation, while former CEO Joseph Dziedzic received $8.7 million. The company also reported a significant increase in its median worker pay, narrowing the CEO-to-median-worker pay ratio from 238 to 86 times.
Integer Holdings: Medical Device CDMO Announces Board Leadership Transition
Integer Holdings announced a leadership transition on its Board of Directors, with Pamela G. Bailey not seeking re-election as independent Chair. Donald J. Spence, a current director, is set to succeed her following the 2026 Annual Meeting of Stockholders. This transition is part of the company's planned long-term value creation strategy and aims to ensure continued collaboration with CEO Payman Khales and the executive team.
[ARS] Integer Holdings Corp SEC Filing
This article reports on an ARS SEC filing by Integer Holdings Corp (ITGR) on April 6, 2026, with a neutral sentiment and low impact. It provides key company information, including market cap, float, industry, and recent news and other SEC filings related to Integer Holdings Corp.
Pamela Bailey to Exit as Chair of Integer Holdings; Donald Spence Set to Succeed
Pamela G. Bailey, current independent Chair of Integer Holdings (NYSE: ITGR), will not seek re-election at the 2026 Annual Meeting. Donald J. Spence, a current board member since 2016, is slated to succeed her as independent Chair. Spence has extensive experience in the medical device industry, having previously served as CEO of Ebb Therapeutics and Lake Region Medical.
Integer Announces Board Leadership Transition
Integer Holdings Corporation (NYSE: ITGR) announced a board leadership transition, with Pamela G. Bailey not seeking re-election as independent Chair. Donald J. Spence, a current director, will assume the role of independent Chair of the Board after the 2026 Annual Meeting of Stockholders on May 20, 2026. This transition follows Ms. Bailey's successful tenure and is expected to maintain close collaboration between the board and the executive team.
Integer lines up Donald Spence as next independent board chair
Integer Holdings Corporation announced that its independent Board Chair, Pamela G. Bailey, will not seek re-election at the 2026 Annual Meeting of Stockholders on May 20, 2026. The Board intends to appoint current director Donald J. Spence as the next independent Chair. Spence, who has served on the Board since 2016, currently chairs the Compensation & Organization Committee and has significant executive experience in the medical device industry.
Integer Holdings (NYSE: ITGR) details 2026 proxy, pay plan and new share reserve
Integer Holdings is seeking stockholder approval for four key items at its 2026 Annual Meeting, including the election of 11 directors, auditor ratification, an advisory vote on executive pay, and the adoption of a new 2026 Omnibus Incentive Plan. The company highlights strong 2025 financial performance with increased sales and adjusted operating income, alongside a compensation philosophy that links executive pay to performance. The proposed incentive plan aims to authorize new shares while maintaining governance best practices and a modest dilution rate.
